BACKGROUND: Children are at risk for psychosocial and adaptive morbidities following diagnosis of and treatment for a pediatric brain tumor. This study examined whether familial/demographic, developmental, diagnostic, or treatment-related variables best predict the acute psychosocial adjustment and adaptive functioning of children soon after an initial diagnosis. PROCEDURE: Participants included 56 children (mean age = 10.72, SD = 4.02) newly diagnosed with a pediatric brain tumor. Parents completed background/demographic forms and completed ratings of children's behavioral and emotional symptoms, and adaptive behavior. Diagnostic and treatment-related information was abstracted from medical records. RESULTS: Parent ratings of behavioral symptoms and adaptive functioning were within normative expectation, although rates of clinical impairment in adaptive functioning exceeded expected rates. A combination of familial/demographic and diagnostic variables were associated with acute functioning. In multiple regressions, tumor size best predicted adaptive functioning after initial diagnosis, whereas tumor location best predicted variance in behavioral symptoms. CONCLUSIONS: Children may be more vulnerable to acute impairment in adaptive functioning following diagnosis of a pediatric brain tumor, but rates of behavioral symptoms were within expectation. Familial, sociodemographic, and diagnostic variables may help to identify those most at risk of impairment. Screening of these factors within tertiary care settings will be useful to identify those most in need of psychosocial care during the initial phases of treatment.
BACKGROUND:Children are at risk for psychosocial and adaptive morbidities following diagnosis of and treatment for a pediatric brain tumor. This study examined whether familial/demographic, developmental, diagnostic, or treatment-related variables best predict the acute psychosocial adjustment and adaptive functioning of children soon after an initial diagnosis. PROCEDURE: Participants included 56 children (mean age = 10.72, SD = 4.02) newly diagnosed with a pediatric brain tumor. Parents completed background/demographic forms and completed ratings of children's behavioral and emotional symptoms, and adaptive behavior. Diagnostic and treatment-related information was abstracted from medical records. RESULTS: Parent ratings of behavioral symptoms and adaptive functioning were within normative expectation, although rates of clinical impairment in adaptive functioning exceeded expected rates. A combination of familial/demographic and diagnostic variables were associated with acute functioning. In multiple regressions, tumor size best predicted adaptive functioning after initial diagnosis, whereas tumor location best predicted variance in behavioral symptoms. CONCLUSIONS:Children may be more vulnerable to acute impairment in adaptive functioning following diagnosis of a pediatric brain tumor, but rates of behavioral symptoms were within expectation. Familial, sociodemographic, and diagnostic variables may help to identify those most at risk of impairment. Screening of these factors within tertiary care settings will be useful to identify those most in need of psychosocial care during the initial phases of treatment.
Authors: Lonnie K Zeltzer; Christopher Recklitis; David Buchbinder; Bradley Zebrack; Jacqueline Casillas; Jennie C I Tsao; Qian Lu; Kevin Krull Journal: J Clin Oncol Date: 2009-03-02 Impact factor: 44.544
Authors: M Douglas Ris; Dean W Beebe; F Daniel Armstrong; John Fontanesi; Emi Holmes; Robert A Sanford; Jeffrey H Wisoff Journal: J Clin Oncol Date: 2008-09-08 Impact factor: 44.544
Authors: Lonnie K Zeltzer; Qian Lu; Wendy Leisenring; Jennie C I Tsao; Christopher Recklitis; Gregory Armstrong; Ann C Mertens; Leslie L Robison; Kirsten K Ness Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-02 Impact factor: 4.254
Authors: Kirsten K Ness; Ann C Mertens; Melissa M Hudson; Melanie M Wall; Wendy M Leisenring; Kevin C Oeffinger; Charles A Sklar; Leslie L Robison; James G Gurney Journal: Ann Intern Med Date: 2005-11-01 Impact factor: 51.598
Authors: Kris Ann P Schultz; Kirsten K Ness; John Whitton; Christopher Recklitis; Brad Zebrack; Leslie L Robison; Lonnie Zeltzer; Ann C Mertens Journal: J Clin Oncol Date: 2007-08-20 Impact factor: 50.717
Authors: Brad J Zebrack; James G Gurney; Kevin Oeffinger; John Whitton; Roger J Packer; Ann Mertens; Norman Turk; Robert Castleberry; ZoAnn Dreyer; Leslie L Robison; Lonnie K Zeltzer Journal: J Clin Oncol Date: 2004-03-15 Impact factor: 50.717
Authors: Kimberly P Raghubar; Jessica Orobio; M Douglas Ris; Andrew M Heitzer; Alexandra Roth; Austin L Brown; M Fatih Okcu; Murali Chintagumpala; David R Grosshans; Arnold C Paulino; Anita Mahajan; Lisa S Kahalley Journal: Pediatr Blood Cancer Date: 2019-05-27 Impact factor: 3.167
Authors: Kimberly P Raghubar; Michael Lamba; Kim M Cecil; Keith Owen Yeates; E Mark Mahone; Christina Limke; David Grosshans; Travis J Beckwith; M Douglas Ris Journal: Pediatr Blood Cancer Date: 2018-06-01 Impact factor: 3.167
Authors: Alexandra K Roth; M Douglas Ris; Jessica Orobio; Judy Xue; Anita Mahajan; Arnold C Paulino; David Grosshans; M Fatih Okcu; Murali Chintagumpala; Lisa S Kahalley Journal: Pediatr Blood Cancer Date: 2019-11-17 Impact factor: 3.167
Authors: Kimberly P Raghubar; E Mark Mahone; Keith Owen Yeates; Kim M Cecil; Monwabisi Makola; M Douglas Ris Journal: Child Neuropsychol Date: 2016-05-26 Impact factor: 2.500
Authors: Yuliang Wang; Anthony Pak Yin Liu; Tatia Mei-Chun Lee; Wilfred Hing Sang Wong; Daniel Yee Tak Fong; Lok Kan Leung; Matthew Ming Kong Shing; Dennis Tak-Loi Ku; Godfrey Chi-Fung Chan; Winnie Wan-Yee Tso Journal: Cancers (Basel) Date: 2022-07-04 Impact factor: 6.575
Authors: Peter L Stavinoha; Martha A Askins; Stephanie K Powell; Natasha Pillay Smiley; Rhonda S Robert Journal: Bioengineering (Basel) Date: 2018-09-11